Elutia Inc. (ELUT) stock
ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.83−0.02 (-2.80%)
Close on Nov 18, 2026Market cap $36.76MP/E –Yield –
Elutia market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Elutia's market cap was $41.74M on Nov 11, 2026, against $26.17M a year earlier. Over the last 5 years it ranged from $8.84M to $111.35M, with a median of $53.23M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $41.74M | +40.9% |
| 2025 | Dec 31, 2025 | $29.62M | -70.5% |
| 2024 | Dec 31, 2024 | $100.59M | +236.7% |
| 2023 | Dec 29, 2023 | $29.88M | -42.0% |
| 2022 | Dec 30, 2022 | $51.55M | +391.2% |
| 2021 | Jan 29, 2021 | $10.50M | +18.7% |
| 2020 | Dec 31, 2020 | $8.84M | – |
See a number that looks wrong?